Related Experiment Video
Updated: Jul 3, 2025

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
Comparative analysis of KRAS4a and KRAS4b splice variants reveals distinctive structural and functional properties
Matthew J Whitley1, Timothy H Tran1, Megan Rigby1
1NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Abstract:
KRAS, the most frequently mutated oncogene in human cancer, produces two isoforms, KRAS4a and KRAS4b, through alternative splicing. These isoforms differ in exon 4, which encodes the final 15 residues of the G-domain and hypervariable regions (HVRs), vital for trafficking and membrane localization. While KRAS4b has been extensively studied, KRAS4a has been largely overlooked. Our multidisciplinary study compared the structural and functional characteristics of KRAS4a and KRAS4b, revealing distinct structural properties and thermal stability. Position 151 influences KRAS4a's thermal stability, while position 153 affects binding to RAF1 CRD protein. Nuclear magnetic resonance analysis identified localized structural differences near sequence variations and provided a solution-state conformational ensemble. Notably, KRAS4a exhibits substantial transcript abundance in bile ducts, liver, and stomach, with transcript levels approaching KRAS4b in the colon and rectum. Functional disparities were observed in full-length KRAS variants, highlighting the impact of HVR variations on interaction with trafficking proteins and downstream effectors like RAF and PI3K within cells.
Insights
KRAS4a, a previously overlooked cancer-associated protein isoform, exhibits distinct structural and functional properties compared to KRAS4b. Understanding these differences is crucial for cancer research.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The KRAS gene is frequently mutated in human cancers.
- KRAS produces two isoforms, KRAS4a and KRAS4b, via alternative splicing.
- KRAS4a has been significantly less studied than KRAS4b.
Purpose of the Study:
- To compare the structural and functional characteristics of KRAS4a and KRAS4b.
- To elucidate the distinct properties arising from alternative splicing in KRAS.
- To investigate the implications of these differences in cancer biology.
Main Methods:
- Multidisciplinary comparative analysis of KRAS4a and KRAS4b.
- Nuclear Magnetic Resonance (NMR) spectroscopy for structural determination.
- Assessment of protein-ligand interactions and cellular trafficking.
Main Results:
- KRAS4a and KRAS4b display distinct structural properties and thermal stability.
- Specific amino acid positions (151 and 153) influence KRAS4a stability and RAF1 CRD binding.
- NMR revealed localized structural differences and conformational ensembles.
- KRAS4a shows significant transcript abundance in specific tissues like the liver and bile ducts.
Conclusions:
- Alternative splicing generates functionally distinct KRAS isoforms with unique cellular roles.
- KRAS4a's distinct structural and functional attributes warrant further investigation in cancer.
- Hypervariable region variations impact protein interactions and downstream signaling pathways.
Related Concept Videos
The Ras Gene
Ras is a...
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Chromatin Structure and RNA Splicing
Leaky Scanning

